RxDoctor Payments Data

Alfonso Fernandez Fente, APRN

Family · Hialeah, FLNPI 1407481757

Payments from drug & device makers

$186in general payments, 2019–2025

Across 10 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$35
  • Lilly USA, LLC$27
  • Amarin Pharma, Inc.$22
  • Novo Nordisk$22
  • Astellas Pharma US Inc$21
  • Abbott$20
  • plus $39 from 2 others

What the payments were for

  • Food & beverage$186100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$186 in reported general payments places this provider in the 35th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$8,824
Medicare patients
24
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide106$114,542
EliquisApixaban100$92,681
JardianceEmpagliflozin67$80,961
XareltoRivaroxaban64$57,122
FarxigaDapagliflozin Propanediol42$45,511
JanuviaSitagliptin Phosphate40$37,081
EntrestoSacubitril/Valsartan33$34,969
GemtesaVibegron34$25,407
TrulicityDulaglutide22$20,933
Synjardy XrEmpagliflozin/Metformin Hcl16$19,041
LinzessLinaclotide23$18,510
MounjaroTirzepatide13$13,864
MyrbetriqMirabegron25$12,523
JanumetSitagliptin Phos/Metformin Hcl11$10,845
BrilintaTicagrelor22$10,825

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$22$114,542106 claims
PfizerEliquis, Premarin$35$98,488113 claims
Lilly USA, LLCTrulicity, Mounjaro$27$34,79735 claims
AbbVieLinzess, Synthroid$20$21,05045 claims
Astellas Pharma US IncMyrbetriq$21$12,52325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 14,618 family providers in Florida.

Other family in Hialeah

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →